| Price | $1.07 |
| Year Range | $0.82 – $1.57 |
| Market Cap | $21M |
| Industry | Biotechnology |
What Is Cocrystal Pharma’s AI Stock Analysis?
Cocrystal Pharma’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Cocrystal Pharma’s momentum in near-real time.
Cocrystal Pharma (COCP) has an AltIndex AI Score of 50/100, currently a Hold signal. The AI Score distills Cocrystal Pharma's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Cocrystal Pharma’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Cocrystal Pharma — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving COCP’s AI Score?
Fundamentals
Revenue for the last quarter was $110,000. This represents a decrease of 53.33% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of 0.00%, suggesting positive year-over-year growth. Net income for the last quarter was $-3.2M. This represents a decrease of 37.63% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 53.97%, which may be a cause for concern. Ebitda for the last quarter was $-3.1M. This represents a decrease of 42.21% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 54.38%, which may be a cause for concern.
See Cocrystal Pharma’s earnings and insider transactions.
Technicals
Today's stock price is $1.07. This represents a decrease of 13.01% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 6.96%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $1.12, which is lower than the previous SMA10 of $1.12. This suggests a potential downward trend in price movement. The RSI is 54.1, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
The business outlook among employees at Cocrystal Pharma is low (an estimate of only 0% of employees have a positive outlook), a concerning sign. Cocrystal Pharma has an estimate of 4,000 visitors to their webpage. The number of visitors is up by 100% in the last couple of months, a bullish trend as this can indicate can increase in customers.
Explore Cocrystal Pharma’s job postings, web traffic and app downloads.
Sentiment & social
Cocrystal Pharma has 1,400 followers on their Twitter page. The number of followers is down by -0% in the last couple of months, indicating a loss in interest in the company.
Track Cocrystal Pharma’s market sentiment.
Frequently Asked Questions: Cocrystal Pharma AI Stock Analysis
Cocrystal Pharma's AltIndex AI Score is 50/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Cocrystal Pharma a Hold (50/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Cocrystal Pharma — company overview, fundamentals, technicals and alternative data, with a recommendation. See the COCP AI Score or sign up to read the full thesis.
